ARDX
Ardelyx, Inc.$5.28+0.12 (+2.33%)Prev Close$5.16·MCap$1.27B·P/E—·Vol1.83M·Yield—
▲
Buys (12M)
2
$3.89M
▼
Sells (12M)
45
$5.46M
◆
Net Activity
Net Seller
$1.57M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at Ardelyx, Inc. (ARDX) has been mixed between buying and selling, with 2 insider purchases totaling $3.89M and 45 insider sales totaling $5.46M. The most recent insider transaction was by Williams Laura A (officer: Chief Patient Officer), who sold $490.5K worth of shares on Jun 22, 2026. Ardelyx, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.27B.
ARDX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 81,898 | $5.99 | $490.5K | 378,195 |
| Jun 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.67 | $236.3K | 1,699,200 |
| May 22, 2026 | Bishop John E | officer: See Remarks | Sell | 2,306 | $6.27 | $14.5K | 336,845 |
| May 22, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 1,846 | $6.27 | $11.6K | 261,066 |
| May 22, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 1,455 | $6.27 | $9.1K | 229,078 |
| May 22, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 54,748 | $6.27 | $343.1K | 1,759,848 |
| May 22, 2026 | Kelliher Mike | officer: Chief Business Officer | Sell | 7,248 | $6.27 | $45.4K | 361,766 |
| May 22, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 7,998 | $6.27 | $50.1K | 422,804 |
| May 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 6,989 | $6.27 | $43.8K | 434,579 |
| May 22, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 3,719 | $6.27 | $23.3K | 149,836 |
| May 19, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.28 | $261.6K | 1,774,781 |
| Apr 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $6.29 | $262.0K | 1,795,614 |
| Mar 18, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.84 | $243.3K | 1,816,448 |
| Feb 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.25 | $260.6K | 1,836,153 |
| Feb 23, 2026 | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026 | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 23, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,567 |
| Feb 23, 2026 | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,918 |
| Feb 23, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026 | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 20, 2026 | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Feb 20, 2026 | Reilly Joseph James | See Remarks | Sell | 4,989 | $5.85 | $29.2K | 0 |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026 | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Feb 20, 2026 | RAAB MICHAEL | President & CEO | Sell | 45,979 | $5.85 | $268.8K | 0 |
| Feb 20, 2026 | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026 | Bishop John E | See Remarks | Sell | 3,178 | $5.85 | $18.6K | 0 |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Jan 9, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025 | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025 | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
| Aug 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,841 | $5.93 | $34.6K | 0 |
| Aug 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 45,687 | $5.93 | $271.0K | 0 |
| Aug 21, 2025 | Renz Justin A | Chief Financial Officer | Sell | 7,037 | $5.93 | $41.7K | 0 |
| Aug 21, 2025 | Kelliher Mike | Chief Business Officer | Sell | 5,417 | $5.93 | $32.1K | 0 |
| Aug 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 15,308 | $5.93 | $90.8K | 0 |
| Aug 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,261 | $5.93 | $37.1K | 0 |
| Jun 16, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.63 | $725.9K | 0 |
| Jun 9, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.69 | $737.3K | 0 |
| May 20, 2025 | Williams Laura A | Chief Medical Officer | Sell | 6,421 | $4.08 | $26.2K | 0 |
Showing 1–50 of 239
1 / 5
ARDX Insider Buying Activity
The following table shows recent insider purchases of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | MOTT DAVID M | director | Buy | 333,333 | $5.84 | $1.95M | 3,302,918 |
| Feb 20, 2026 | MOTT DAVID M | Director | Buy | 333,333 | $5.84 | $1.95M | 0 |
| Jun 16, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.63 | $725.9K | 0 |
| Jun 9, 2025 | MOTT DAVID M | Director | Buy | 200,000 | $3.69 | $737.3K | 0 |
ARDX Insider Selling Activity
The following table shows recent insider sales of Ardelyx, Inc. (ARDX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 81,898 | $5.99 | $490.5K | 378,195 |
| Jun 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.67 | $236.3K | 1,699,200 |
| May 22, 2026 | Bishop John E | officer: See Remarks | Sell | 2,306 | $6.27 | $14.5K | 336,845 |
| May 22, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 1,846 | $6.27 | $11.6K | 261,066 |
| May 22, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 1,455 | $6.27 | $9.1K | 229,078 |
| May 22, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 54,748 | $6.27 | $343.1K | 1,759,848 |
| May 22, 2026 | Kelliher Mike | officer: Chief Business Officer | Sell | 7,248 | $6.27 | $45.4K | 361,766 |
| May 22, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 7,998 | $6.27 | $50.1K | 422,804 |
| May 22, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 6,989 | $6.27 | $43.8K | 434,579 |
| May 22, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 3,719 | $6.27 | $23.3K | 149,836 |
| May 19, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.28 | $261.6K | 1,774,781 |
| Apr 17, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,668 | $6.29 | $262.0K | 1,795,614 |
| Mar 18, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $5.84 | $243.3K | 1,816,448 |
| Feb 25, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 41,666 | $6.25 | $260.6K | 1,836,153 |
| Feb 23, 2026 | Bishop John E | officer: See Remarks | Sell | 3,179 | $5.85 | $18.6K | 339,538 |
| Feb 23, 2026 | Williams Laura A | officer: See Remarks | Sell | 8,176 | $5.85 | $47.8K | 437,066 |
| Feb 23, 2026 | Foster Eric Duane | officer: Chief Commercial Officer | Sell | 10,438 | $5.85 | $61.0K | 427,233 |
| Feb 23, 2026 | Brady James Parker | officer: Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 263,221 |
| Feb 23, 2026 | Reilly Joseph James | officer: See Remarks | Sell | 4,991 | $5.85 | $29.2K | 152,394 |
| Feb 23, 2026 | RAAB MICHAEL | director, officer: President & CEO | Sell | 45,980 | $5.85 | $268.8K | 1,862,567 |
| Feb 23, 2026 | Hohenleitner Susan | officer: Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 230,780 |
| Feb 23, 2026 | Kelliher Mike | officer: See Remarks | Sell | 9,595 | $5.85 | $56.1K | 365,827 |
| Feb 20, 2026 | Reilly Joseph James | See Remarks | Sell | 4,989 | $5.85 | $29.2K | 0 |
| Feb 20, 2026 | Foster Eric Duane | Chief Commercial Officer | Sell | 10,439 | $5.85 | $61.0K | 0 |
| Feb 20, 2026 | Williams Laura A | See Remarks | Sell | 8,176 | $5.85 | $47.8K | 0 |
| Feb 20, 2026 | RAAB MICHAEL | President & CEO | Sell | 45,979 | $5.85 | $268.8K | 0 |
| Feb 20, 2026 | Kelliher Mike | See Remarks | Sell | 9,595 | $5.85 | $56.1K | 0 |
| Feb 20, 2026 | Hohenleitner Susan | Chief Financial Officer | Sell | 2,033 | $5.85 | $11.9K | 0 |
| Feb 20, 2026 | Bishop John E | See Remarks | Sell | 3,178 | $5.85 | $18.6K | 0 |
| Feb 20, 2026 | Brady James Parker | Chief Human Resources Officer | Sell | 2,543 | $5.85 | $14.9K | 0 |
| Jan 9, 2026 | Williams Laura A | officer: Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 361,563 |
| Jan 8, 2026 | Williams Laura A | Chief Patient Officer | Sell | 50,000 | $6.98 | $348.9K | 0 |
| Nov 21, 2025 | Reilly Joseph James | See Remarks | Sell | 11,086 | $5.54 | $61.4K | 0 |
| Nov 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 5,814 | $5.54 | $32.2K | 0 |
| Nov 21, 2025 | Kelliher Mike | See Remarks | Sell | 5,560 | $5.54 | $30.8K | 0 |
| Nov 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,995 | $5.54 | $33.2K | 0 |
| Nov 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 46,887 | $5.54 | $259.6K | 0 |
| Nov 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,426 | $5.54 | $35.6K | 0 |
| Aug 26, 2025 | Williams Laura A | Chief Patient Officer | Sell | 80,000 | $6.12 | $489.7K | 0 |
| Aug 21, 2025 | GRAMMER ELIZABETH A | See Remarks | Sell | 5,841 | $5.93 | $34.6K | 0 |
| Aug 21, 2025 | RAAB MICHAEL | President & CEO | Sell | 45,687 | $5.93 | $271.0K | 0 |
| Aug 21, 2025 | Renz Justin A | Chief Financial Officer | Sell | 7,037 | $5.93 | $41.7K | 0 |
| Aug 21, 2025 | Kelliher Mike | Chief Business Officer | Sell | 5,417 | $5.93 | $32.1K | 0 |
| Aug 21, 2025 | Foster Eric Duane | Chief Commercial Officer | Sell | 15,308 | $5.93 | $90.8K | 0 |
| Aug 21, 2025 | Williams Laura A | Chief Patient Officer | Sell | 6,261 | $5.93 | $37.1K | 0 |
| May 20, 2025 | Williams Laura A | Chief Medical Officer | Sell | 6,421 | $4.08 | $26.2K | 0 |
ARDX Insiders
Similar Stocks to ARDX
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B